ADSTILADRIN | FDA
Mar 24, 2026 · STN: BLA 125700 Proper Name: nadofaragene firadenovec-vncg Tradename: ADSTILADRIN Manufacturer: Ferring …
ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in …
Adstiladrin: Uses, Dosage, Side Effects & Warnings - Drugs.com
Apr 1, 2026 · Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG) …
Adstiladrin | European Medicines Agency (EMA)
Mar 27, 2026 · Adstiladrin is used when the cancer has not responded to treatment with Bacillus Calmette-Guérin (BCG), a standard …
Nadofaragene firadenovec-vncg (urinary bladder route)
May 1, 2026 · Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG) …
Adstiladrin Bladder Cancer Treatment - The Urology Group Virginia
Adstiladrin (nadofaragene firadenovec-vncg) is a medicine used to treat adults with a type of bladder cancer called high-risk non …
Nadofaragene firadenovec - Wikipedia
Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. [1][5][6] It is …
Efficacy & Clinical Trial Data | ADSTILADRIN® (nadofaragene ...
The safety and efficacy of ADSTILADRIN (nadofaragene firadenovec-vncg) were evaluated in CS-003, an open-label, multicenter, …
First Bladder Cancer Patient Dosed with Commercially ...
Sep 12, 2023 · First Bladder Cancer Patient Dosed with Commercially Available Intravesical Gene Therapy ADSTILADRIN® …
Nadofaragene firadenovec-vncg given into the bladder ...
Dec 19, 2024 · Nadofaragene Firadenovec-vncg (Adstiladrin®) is a gene therapy put directly into the bladder used to treat some …